Not only does IDO activation deplete essential Trp from the TME, but it also causes accumulation of Kyn which generates a tumor-promoting environment by converting naïve CD4+ T cell development into regulatory T cells (Tregs) that facilitate tolerance to tumors and counteract anti-tumor immune cells [1, 7]. This evidence concerns the gene IDO1 and neoplasm.